Integral Diagnostics Ltd (IDX) - Total Assets
Based on the latest financial reports, Integral Diagnostics Ltd (IDX) holds total assets worth AU$1.43 Billion AUD (≈ $1.01 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See IDX total equity for net asset value and shareholders' equity analysis.
Integral Diagnostics Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Integral Diagnostics Ltd's total assets have evolved over time, based on quarterly financial data.
Integral Diagnostics Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Integral Diagnostics Ltd's total assets of AU$1.43 Billion consist of 6.7% current assets and 93.3% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 3.7% |
| Accounts Receivable | AU$28.46 Million | 2.0% |
| Inventory | AU$2.52 Million | 0.2% |
| Property, Plant & Equipment | AU$468.81 Million | 32.9% |
| Intangible Assets | AU$59.88 Million | 4.2% |
| Goodwill | AU$802.50 Million | 56.3% |
Asset Composition Trend (2012–2025)
This chart illustrates how Integral Diagnostics Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see IDX market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Integral Diagnostics Ltd's current assets represent 6.7% of total assets in 2025, an increase from 0.0% in 2012.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, up from 0.0% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 56.3% of total assets.
Integral Diagnostics Ltd Competitors by Total Assets
Key competitors of Integral Diagnostics Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €84.58 Million |
|
Inoviq Ltd
AU:IIQ
|
Australia | AU$24.52 Million |
|
Bcal Diagnostics Ltd
AU:BDX
|
Australia | AU$7.17 Million |
|
Imagion Biosystems Ltd
AU:IBX
|
Australia | AU$932.48K |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
Cryosite Ltd
AU:CTE
|
Australia | AU$19.46 Million |
Integral Diagnostics Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.68 | 0.86 | 1.13 |
| Quick Ratio | 0.66 | 0.84 | 1.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$-45.38 Million | AU$-12.33 Million | AU$9.47 Million |
Integral Diagnostics Ltd - Advanced Valuation Insights
This section examines the relationship between Integral Diagnostics Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.29 |
| Latest Market Cap to Assets Ratio | 0.41 |
| Asset Growth Rate (YoY) | 91.7% |
| Total Assets | AU$1.43 Billion |
| Market Capitalization | $585.79 Million USD |
Valuation Analysis
Below Book Valuation: The market values Integral Diagnostics Ltd's assets below their book value (0.41x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Integral Diagnostics Ltd's assets grew by 91.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Integral Diagnostics Ltd (2012–2025)
The table below shows the annual total assets of Integral Diagnostics Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$1.43 Billion ≈ $1.01 Billion |
+91.66% |
| 2024-06-30 | AU$744.28 Million ≈ $526.62 Million |
-11.29% |
| 2023-06-30 | AU$839.01 Million ≈ $593.65 Million |
+7.15% |
| 2022-06-30 | AU$783.01 Million ≈ $554.03 Million |
+19.56% |
| 2021-06-30 | AU$654.90 Million ≈ $463.38 Million |
+11.58% |
| 2020-06-30 | AU$586.91 Million ≈ $415.28 Million |
+86.52% |
| 2019-06-30 | AU$314.67 Million ≈ $222.65 Million |
+60.93% |
| 2018-06-30 | AU$195.53 Million ≈ $138.35 Million |
+2.70% |
| 2017-06-30 | AU$190.38 Million ≈ $134.71 Million |
+5.12% |
| 2016-06-30 | AU$181.10 Million ≈ $128.14 Million |
+16.07% |
| 2015-06-30 | AU$156.04 Million ≈ $110.41 Million |
+1792.52% |
| 2014-06-30 | AU$8.24 Million ≈ $5.83 Million |
+224.43% |
| 2013-06-30 | AU$2.54 Million ≈ $1.80 Million |
-16.46% |
| 2012-06-30 | AU$3.04 Million ≈ $2.15 Million |
-- |
About Integral Diagnostics Ltd
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as … Read more